Home | FibroGen | BioPharma for Anemia, Fibrosis, Cancer

We create first-in-class medicines to treat chronic and life-threatening conditions such as anemia, idiopathic pulmonary fibrosis, and pancreatic cancer.

Pipeline

We are developing products with the potential to change lives.

Clinical Trials

We are dedicated to responsibly developing groundbreaking therapies for serious and life-threatening diseases.

FibroGen China

We have taken an unprecedented approach to introducing world-class innovations in China.

May 27, 2020: FibroGen to Present at Upcoming Investor Conferences
May 21, 2020: European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Roxadustat
May 8, 2020: FibroGen to Present at Bank of America Securities 2020 Health Care Conference
May 7, 2020: FibroGen Reports First Quarter 2020 Financial Results
Apr 24, 2020: FibroGen To Report First Quarter 2020 Financial Results

View All

FG Culture

“Being surrounded by so many intelligent, kind, and professional people makes FibroGen a wonderful place to work.”

Associate Scientist II, Cell Biology

Contact Our Company

We are growing a dedicated team committed to innovation and helping patients worldwide.